# Bath & Body Works Inc. (BBWI) fundamentals

Data as of 2026-11-04. NYSE, United States. Sector: Consumer Cyclical / Specialty Retail. Price $22.61, market value $4.6 billion.

## Valuation
- **P/E (trailing): 6.0×** (5-yr avg 9.8×, 3-yr avg 9.1×). Bath & Body Works Inc. trades at 6.0× trailing earnings, well below its own five-year average of 9.8×: cheap by its own standards. The Consumer Cyclical median in the September 2026 study was 19.5×. Forward P/E is 8.1×, higher than trailing, so analysts expect earnings to fall.
- **Price / sales: 0.6×**. Each dollar of revenue is priced at 0.6×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Free-cash-flow yield: 22.6%** (5-yr avg 10.5%). Free cash flow equals 22.6% of the market value, above its five-year average of 10.5%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 16.8%**. The inverse of the P/E: 16.8% of the price is earned each year.

## Profitability
- **Gross margin: 44.1%**. Bath & Body Works Inc. keeps 44.1% of revenue after the direct cost of what it sells.
- **Operating margin: 16.7%**. 16.7% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 8.9%**. 8.9% of each dollar of sales reaches the bottom line.
- **Return on equity: -50.7%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 57.5%**. Return on all capital, debt included, is 57.5%: comfortably above what that capital costs.
- **Return on assets: 15.4%**. Each dollar of assets produces 15.4% of profit.

## Growth
- **Revenue growth (1 yr): -0.2%** (3-yr -1.2%/yr, 5-yr 2.5%/yr). Revenue fell 0.2% over the last year, against 2.5% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): -13.9%** (3-yr -3.2%/yr, 5-yr 0.7%/yr). Earnings per share fell 13.9%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 2.0%/yr**. Free cash flow has compounded at 2.0% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Current ratio: 1.27** (quick 1.27). Current assets cover the next year's liabilities 1.27 times.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend yield: 3.54%** ($0.80 per share, trailing). Bath & Body Works Inc. yields 3.54%, an income-level yield.
- **Payout ratio: 26%**. 26% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 5**. 5 straight years of increases.
- **Dividend growth (5 yr): 27.0%/yr** (1-yr 0.0%). The dividend has compounded at 27.0% a year over five years, doubling roughly every 3 years at that pace.

## Analyst view
- **Analyst consensus: hold** (15 analysts). 15 analysts cover Bath & Body Works Inc.; the consensus is hold, with an average price target of $24.20 (+7% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -2.2%** (YTD 17.8%, 3-mo 10.6%). The shares are down 2.2% over twelve months including dividends.
- **From 52-week high: -9.3%** (58.3% above the low). Trading 9% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 73**. An RSI of 73 is in overbought territory; short-term pullbacks are common from here.
- **Beta (1 yr): 1.30** (volatility 60%). Beta of 1.30 against the S&P 500: the shares move much more than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BBWI · Page: https://foliofundamentals.com/stocks/bbwi

Not investment advice.